Canine leishmaniasis in Southern Italy: A role for nitric oxide released from activated macrophages in asymptomatic infection?

Parasites and Vectors

Volumn 1, Issue 1, 2008, Pages

  Panaro, Maria A ^a   Brandonisio, Olga ^a   De Caprariis, Donato ^a   Cavallo, Pasqua ^a   Cianciulli, Antonia ^a   Mitolo, Vincenzo ^a   Otranto, Domenico ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE DONOR; NITRITE;

ARTICLE; CELL CULTURE; CHEMICAL REACTION; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DOG; ENDEMIC DISEASE; FOLLOW UP; ITALY; LABORATORY TEST; LEISHMANIA INFANTUM; LEISHMANIASIS; LONG TERM CARE; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTECTION; PROTOZOAL INFECTION; SOUTHERN EUROPE; SUPERNATANT; SYMPTOMATOLOGY;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 64949141584     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-1-10     Document Type: Article

References (37)

1. Immunology of canine leishmaniasis. CL Barbieri, Parasite Immunol 2006 28 329 337 10.1111/j.1365-3024.2006.00840.x 16842269
2. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis. F Dantas-Torres, Vet Parasitol 2007 149 139 146 10.1016/j.vetpar.2007.07.007 17703890
3. A century of leishmaniasis in Alpes-Maritimes, France. P Marty A Izri C Ozon P Haas E Rosenthal P Del Giudice J Godenir E Coulibaly M Gari-Toussaint P Delaunay B Ferrua H Haas F Pratlong Y Le Fichoux, Ann Trop Med Parasitol 2007 101 563 574 17877875
4. The current status of zoonotic leishmaniases and approaches to disease control. M Gramiccia L Gradoni, Int J Parasitol 2005 35 1169 1180 10.1016/j.ijpara.2005.07.001 16162348
5. TDR Disease Portfolio. http://www.who.int/tdr/diseases/default.htm
6. Epidemiology and direct medical costs of human leishmaniasis in Italy. A Mannocci G La Torre G Chiaradia C De Waure MT Mainelli A Cernigliaro S Bruno W Ricciardi, J Prev Med Hyg 2007 48 27 36 17506235
7. Monitoring of canine leishmaniasis in northern Italy: an update from a scientific network. G Capelli R Baldelli E Ferroglio C Genchi L Gradoni M Gramiccia M Maroli M Mortarino M Pietrobelli L Rossi M Ruggiero, Parassitologia 2004 46 193 197 15305715
8. Incidences of canine leishmaniasis in an endemic area of southern Italy. P Paradies G Capelli C Cafarchia D de Caprariis M Sasanelli D Otranto, J Vet Med B Infect Dis Vet Public Health 2006 53 6 295 298 16907963
9. Canine leishmaniasis in the Gargano promontory (Apulia, South Italy). O Brandonisio G Carelli L Ceci B Consenti A Fasanella V Puccini, Eur J Epidemiol 1992 8 273 276 10.1007/BF00144813 1644148
10. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. R Molina C Amela J Nieto M San-Andrés F González JA Castillo J Lucientes J Alvar, Trans R Soc Trop Med Hyg 1994 88 491 493 10.1016/0035-9203(94)90446-4 7570854
11. Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons. G Oliva A Scalone V Foglia Manzillo M Gramiccia A Pagano T Di Muccio L Gradoni, J Clin Microbiol 2006 44 1318 1322 16597857 10.1128/JCM.44.4.1318-1322.2006
12. Recombinant K39 dipstick immunochromatographic test: a new tool for the serodiagnosis of canine leishmaniasis. D Otranto P Paradies M Sasanelli N Leone D de Caprariis J Chirico R Spinelli G Capelli O Brandonisio, J Vet Diagn Invest 2005 17 32 37 15690948
13. In vitro assays for evaluation of drug activity against Leishmania spp. L Fumarola R Spinelli O Brandonisio, Res Microbiol 2004 155 224 230 10.1016/j.resmic.2004.01.001 15142618
14. Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in Southern Italy. M Maroli V Mizzoni C Siragusa A D'Orazi L Gradoni, Med Vet Entomol 2001 15 358 363 10.1046/j.0269-283x.2001.00321.x 11776454
15. Efficacy of a combination of 10% imidacloprid/50% permethrin for the prevention of leishmaniasis in kennelled dogs in an endemic area. D Otranto P Paradies RP Lia MS Latrofa G Testini C Cantacessi N Mencke G Galli G Capelli D Stanneck, Vet Parasitol 2007 144 270 278 10.1016/j.vetpar.2006.09.012 17258860
16. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivates. J Maul A Ransijn Y Buchmüller-Rouiller, J Leuk Biol 1991 49 73 82
17. Evaluation of nitric oxide production by Leishmania infantum-infected dog macrophages. MA Panaro A Fasanella S Lisi V Mitolo A Andriola O Brandonisio, Immunopharmacol Immunotoxicol 1998 20 147 158 10.3109/08923979809034814 9543705
18. Inducible nitric oxide synthase expression in Leishmania-infected dog macrophages. M Sisto O Brandonisio MA Panaro A Acquafredda D Leogrande A Fasanella T Trotta L Fumarola V Mitolo, Comp Immunol Microbiol Infect Dis 2001 24 247 54 10.1016/S0147-9571(01)00013-3 11561959
19. The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist. PE Kima, Int J Parasitol 2007 37 1087 1096 10.1016/j.ijpara.2007.04.007 17543969
20. Investigations on the in vitro metacyclogenesis of a visceral and a cutaneous human strain of Leishmania infantum. M Louassini FJ Adroher MR Foulquie R Benitez, Acta Trop 1998 70 355 368 10.1016/S0001-706X(98)00041-2 9777720
21. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. AH Ding CF Nathan DJ Stuehr, J Immunol 1988 141 2407 2412 3139757
22. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. C Bogdan M Röllinghoff A Diefenbach, Curr Opin Immunol 2000 12 64 76 10.1016/S0952-7915(99)00052-7 10679404
23. Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway. I Vouldoukis JC Drapier AK Nussler Y Tselentis OA Da Silva M Gentilini DM Mossalayi L Monjour B Dugas, Antimicrob Agents Chemother 1996 40 253 256 8787918
24. Infection of a canine macrophage cell line with Leishmania infantum: determination of nitric oxide production and anti-leishmanial activity. E Pinelli D Gebhard AM Mommaas M van Hoeij JA Langermans EJ Ruitenberg VP Rutten, Vet Parasitol 2000 92 181 189 10.1016/S0304-4017(00)00312-5 10962155
25. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes. MA Panaro A Acquafredda S Lisi DD Lofrumento V Mitolo M Sisto A Fasanella T Trotta F Bertani B Consenti O Brandonisio, Comp Immunol Microbiol Infect Dis 2001 24 187 195 10.1016/S0147-9571(00)00026-6 11440191
26. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. JL Lemesre P Holzmuller M Cavaleyra RB Goncalves G Hottin G Papierok, Vaccine 2005 23 2825 2840 10.1016/j.vaccine.2004.11.061 15780731
27. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN-gamma resulting in nitric oxide-mediated amastigote apoptosis. P Holzmuller M Cavaleyra J Moreaux R Kovacic P Vincendeau G Papierok JL Lemesre, Vet Immunol Immunopathol 2005 106 247 257 10.1016/j.vetimm.2005.03.001 15963823
28. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. JL Lemesre P Holzmuller RB Goncalves G Bourdoiseau C Hugnet M Cavaleyra G Papierok, Vaccine 2007 25 4223 4234 10.1016/j.vaccine.2007.02.083 17395339
29. Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro. CA Rodrigues LF Batista MC Teixeira AM Pereira PO Santos GG de Sa Oliveira LA de Freitas PS Veras, Vet Parasitol 2007 143 197 205 10.1016/j.vetpar.2006.09.003 17045743
30. Leishmania spp.: mechanisms of toxicity of nitrogen oxidation products. J Maul A Ransijn, Exp Parasitol 1997 87 98 111 10.1006/expr.1997.4205 9326885
31. Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. P Holzmuller D Sereno M Cavaleyra I Mangot S Daulouede P Vincendeau JL Lemesre, Infect Immun 2002 70 3727 3735 12065515 10.1128/IAI.70.7.3727-3735.2002
32. Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. J Mookerjee Basu A Mookerjee P Sen S Bhaumik P Sen S Banerjee K Naskar SK Choudhuri B Saha S Raha S Roy, Antimicrob Agents Chemother 2006 50 1788 1797 16641451 10.1128/AAC.50.5.1788-1797.2006
33. Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum. P Holzmuller D Sereno JL Lemesre, Antimicrob Agents Chemother 2005 49 4406 4409 16189135 10.1128/AAC.49.10.4406-4409.2005
34. Evidences for iNOS expression and nitric oxide production in the human macrophages. MA Panaro O Brandonisio A Acquafredda M Sisto V Mitolo, Curr Drug Targets Immune Endocr Metabol Disord 2003 3 210 221 10.2174/1568008033340216 12871028
35. Evaluation of transformation growth factor beta1, interleukin-10, and interferon-gamma in male symptomatic and asymptomatic dogs naturally infected by Leishmania (Leishmania) chagasi. AP Corra AC Dossi R de Oliveira Vasconcelos DP Munari VM de Lima, Vet Parasitol 2007 143 267 274 10.1016/j.vetpar.2006.08.023 16979825
36. Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response. C Brachelente N Muller MG Doherr U Sattler M Welle, Vet Pathol 2005 42 166 175 10.1354/vp.42-2-166 15753470
37. Splenic immune responses during canine visceral leishmaniasis. D Strauss-Ayali G Baneth CL Jaffe, Vet Res 2007 38 547 564 10.1051/vetres:2007015 17540157